Source:BIRD-group British Ivermectin Recommendation Development
Ivermectin is a safe medicine that is proving to be effective in the fight against Covid 19.
British Ivermectin Recommendation Development (BIRD) is campaigning for UK approval for ivermectin to help it beat Covid
The First International Ivermectin for Covid Conference | Held 24th to 25th April 2021 | Online
The first-ever conference focusing on the use of ivermectin (IVM) as a prophylaxis and treatment for covid-19 was held online April 24-25 2021.
Medical experts from around the world joined together to present the very latest real world research on repurposing this safe drug that has the ability to transform global efforts to fight the pandemic.
Dr. Tess Lawrie presents the latest systematic review evidence from RCTs and a selection of resource, equity, acceptability and feasibility considerations related to ivermectin use.
Dr. Tess Lawrie
Tess (MBBCh, PhD), is the Director of E-BMC Ltd, and EbMCsquared, a community interest research company. Tess is committed to improving the quality of healthcare through rigorous research. Her range of research expertise, based on research experience in both developing and developed countries, uniquely positions her to evaluate and design research for a variety of healthcare settings. Tess is a frequent member of technical teams responsible for developing international guidelines. Her peer-reviewed publications have received in excess of 3000 citations and her ResearchGate score is among the top 5% of ResearchGate members.